First patient dosed with DISP-10 in Dispatch Bio’s cancer trial
Dispatch Bio has dosed the first participant in a Phase I clinical trial aimed at evaluating the efficacy and safety…
Dispatch Bio has dosed the first participant in a Phase I clinical trial aimed at evaluating the efficacy and safety…
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases. These…
Phantom Neuro has secured approval to initiate its first-in-human trial of the Phantom X system, a minimally invasive muscle-machine interface,…
Zebra Technologies and Aiva Health have collaborated to support hands-free nurse workflows with Aiva's AI-powered solution. This partnership integrates Aiva’s…
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Replimune Group’s biologics licence application…
BioNTech and DualityBio reported encouraging data from a Phase II cohort of their global clinical study evaluating the efficacy of…
Amicus Brain Innovations has launched an AI-based application, known as Amicus Insightful Navigation to Enrich Relationships, Amplify Connections, and Togetherness…
Indonesia’s Ministry of Health has selected GE HealthCare to supply more than 300 computed tomography (CT) scanners to public hospitals…
Clarity Pediatrics has secured $14.5m in a Series A funding round for supporting the planned obesity services launch in early…
Fisher-Titus Medical Center in the US has improved healthcare access for patients in northern Ohio by deploying the Luma Health…